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DENSITY IN PATIENTS WITH PROSTATE CANCER UNDERGOING
ANDROGEN DEPRIVATION THERAPY: SYSTEMATIC REVIEW AND
META-ANALYSIS
H. Bessar 1,*, A. Negida 1, Y. Hani 1, A. Menshawy 3, E. Ghanem2, A. Adel 2, N.
Atallah 2, H. Ahmed 2. 1 Zagazig University, Egypt; 2Al Azhar University,
Egypt; 3Al Menouﬁa University, Egypt
Aim: This study aims at synthesizing evidence from published RCTs about
safety and efﬁcacy of Zoledronic acid (ZA) on bone mineral density (BMD)
for prostate cancer (PCa) patients undergoing androgen deprivation ther-
apy (ADT).
Methods: We searched PubMed through September 2014 using relevant
key words "zoledronic acid", "prostate cancer", and "bone". Data were
extracted from eligible studies, quality was assessed in strict accordance to
Cochrane handbook and data were analyzed using RevMan 5.3 for
windows.
Results: Eight RCTs with a total of 713 patients were eligible for this
study. The pooled mean difference of percentage change in BMD between
ZA and control group favored the ZA group than the control group in
terms of: lumbar spine (MD¼7.80%, 95% CI¼[5.80, 9.80]), total hip
(MD¼3.76%, 95% CI¼[3.18:4.35]) and femoral neck (MD¼3.75%, 95% CI¼
[2:84:4.65]). Of the six adverse events we analyzed (arthralgia, con-
stipation, fatigue, fever, respiratory infection and hot ﬂashes), fever and
fatigue were more common in Zoledronic acid group than control group
(RR¼1.49, 95% CI¼[1.04, 2.12] and RR¼4.27, 95% CI¼[1.59,11.44])
respectively.
Conclusion: Intravenous ZA was safe and tolerated in this population. ZA
achieved therapeutic success (>3% change in BMD) in patients with PCa
undergoing ADT with less adverse events.
0912: ANTIMICROBIAL RESISTENCE IN URINARY TRACT ISOLATES
ASSOCIATED WITH URETERIC STENTS
A. McPhee 1,*, L. Cottom 2, B. Jones 2. 1Gartnavel General Hospital, UK;
2Glasgow Royal Inﬁrmary, UK
Aim: 1. To investigate the microorganisms responsible for UTI in patients
with indwelling J ureteral stents. 2. Compare the frequency distribution of
urinary isolates against Health Protection Scotland data for UTI. 3.
Compare the antimicrobial susceptibility pattern of the isolates against
Health Protection Scotland Data.
Methods: We analysed 6 months theatre records to identify any patients
with an insertion, removal or change or ureteral stent. We then examined
our electronic clinical record system (Clinical Portal) and microbiology
electronic record system (TelePath) for positive urinary cultures. Identi-
fying all positive urine cultures taken while a stent was in situ and
assessing their antimicrobial proﬁles. Finally we assessed the frequency of
individual urinary isolates and compared this to epidemiological data from
the Health Protection Scotland (HPS).
Results: A Statistically Signiﬁcant difference in the distribution of urinary
isolates was noted in our study, X2¼414.951 (p<0.0001), was demon-
strated when compared to HPS epidemiological data.
Our study population demonstrated greater resistance to comparable an-
tibiotics. A statistically signiﬁcant increase in E.Coli resistance towards
Ciproﬂoxacin (p¼0.01), Co-amoxiclav (p¼0.05), Gentamicin (p<0.01) &
Trimethoprim (p<0.01) was demonstrated
Conclusion: Our study shows that urinary isolates associatedwith ureteral
stents were more resistant to antibiotics used as empirical therapy and
peri-operative prophylaxis.
0928: DOES INKING PROSTATE BIOPSIES HELP PREDICT OUTCOMES IN
PROSTATE CANCER?
G. Whittaker 1,*, S. Pomplun 2, A. Chandra 1,2, G. Marra 2, C. Brown2, G.
Muir 2, P. Dasgupta 1,2, H. Yamamoto 1,2. 1King's College London, UK;
2Guy's and St Thomas' NHS Foundation Trust, UK
Aim: To investigate whether capsule-to-cancer distance (CCD) in trans-
rectal ultrasound-guided prostate biopsy (TRUS Bx) samples was useful inpredicting clinical and pathological outcomes in patients undergoing
radical prostatectomy (RP) for prostate cancer (PCa).
Methods: We collected clinical and pathological data for patients who
underwent TRUS Bx and subsequent RP at King’s College Hospital between
April 2011 and October 2013. Distance from the inked capsular end to
cancer in TRUS Bx samples weremeasured by consultant histopathologists.
Tumour on whole-mount RP specimens were also marked, scanned, and
measured for proximity of tumour to the posterior capsule. All statistical
analyses were conducted using Microsoft Excel and GraphPad Prism 5.0.
Results: Out of 310 patients who had inked TRUS Bxs, 46 patients subse-
quently underwent RP. 21.7% had a minimum CCD (MCCD) of 0mm as
assessed by TRUS Bx. TRUS-MCCDwas signiﬁcantly less in patients with an
RP-MCCD of 0mm (p¼0.047). TRUS-MCCD >2mm was associated with
MCCD >0mm in RP specimens (p¼0.03). MCCD did not predict patholog-
ical stage, Gleason score, biochemical recurrence, or margin status.
Conclusion: TRUS-MCCD did not predict ﬁnal pathological stage or onco-
logical outcome after RP. TRUS-MCCD predicted RP-MCCD which could aid
surgical planning. Further research with a larger cohort is necessary.
0937: DOES ENHANCEMENT OF RENAL TUMOUR ON COMPUTED
TOMOGRAPHY IMAGING CORRELATE TO HISTOLOGICAL TYPE OR
GRADE OF TUMOUR?
K. Randhawa, A. Downey*, M. O'Neill, A. Macleod, C.
Mulholland. Altnagelvin Hospital, UK
Aim: Prognosis for renal cell carcinoma depends on stage, grade and his-
tology of tumour. There is increasing evidence that degree of enhancement
betweenpre andpost contrastCT images canassist indetermininggradeand
histology of renal tumours. We investigated whether enhancement on CT
correlated to particular histological types or grades of tumour in our centre.
Methods: Data was collected from 93 patients with renal tumours using
from December 2012 to March 2014. 34 were ineligible (29 no histology, 1
colonic met, 4 benign). Contrast enhancement was deﬁned as >20HU and
measured using local imaging programme.
Results: Of 59 eligible patients, 16 underwent CT with both pre and post
contrast phase. 14 had enhancing lesions; 6 were grade II (mean
enhancement 25.3HU to 74HU), 7 were grade III (31.8HU to 74.14) and 1
was grade IV (42HU - 134). 1 patient wasn't graded on the pathology
report. Therewas no difference between the degree of enhancement in the
different histological subtypes.
Conclusion: Our study showed there was no signiﬁcant difference in
contrast enhancement between grade and histological subtype of RCC.
Further evaluation with a larger patient group could help determine any
correlation between tumour characteristics and degree of contrast
enhancement.
0943: THE DIAGNOSTIC VALUE OF MRI-BASED PSA DENSITY TO
PREDICT THE OUTCOME OF PRIMARY TRANSPERINEAL SECTOR-
GUIDED PROSTATE BIOPSY
F. MacAskill 1,*, D. Eldred-Evans 2, R. Popert 2, T. Carr 1, M. Van
Hemelrijck 2, K. Wolfe 1, S. Liyanage 1. 1 Southend University Hospital, UK;
2Guy's and St Thomas' NHS Foundation Trust, UK
Aim: This study aimed at determining the diagnostic value of MRI-based
PSA density (MR-PSAD) for the presence of prostate cancer on subsequent
transperineal sector-guided prostate biopsies (TPSBx).
Methods: Consecutive biopsy-naive men undergoing primary TPSBx be-
tween 2007 and 2014 were considered. A systematic biopsy protocol was
used. Using MRI, an ellipsoid approximation was used to calculate volume.
Histological outcomes were assessed for the presence of any cancer or sig-
niﬁcant cancer, deﬁnedas either thepresenceofGleason4or4mmtumour
core length (G4) or Gleason 4 or 6mm tumour core length (G6). Receiver
operated characteristics were created and areas under the curve (AUC)with
95% conﬁdence intervals (CI) were compared for PSA and MR-PSAD.
Results: A total of 659 men were evaluated with mean (±SD) age 63 (±9)
years, PSA 8.2 (±5.6) mcg/l, prostate volume 48 (±27) cc and MR-PSAD 0.2
(±0.18) mcg/l/cc. The AUC (95% CI) was signiﬁcantly better for MR-PSAD
than PSA for all cancer deﬁnitions (p0.001): 0.73 (0.69-0.77) vs. 0.61
(0.56-0.65) for any cancer; 0.75 (0.71-0.79) vs. 0.66 (0.61-0.70) for G4; 0.77
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<0.1mcg/l/cc were 85%, 92% and 91% respectively.
Conclusion: MR-PSAD is a signiﬁcantly better predictor of biopsy out-
comes than PSA.
0948: OUTCOMES FOR TRANSPERINEAL TEMPLATE GUIDED PROSTATE
BIOPSY
M. Ahmed*, N. Thakare, F. Chinegwundoh. Barts NHS Trust, UK
Aim: Transperineal template prostate biopsy (TMP) is gaining increasing
popularity as a diagnostic modality for prostate cancer (CaP). We aim to
present our audit data for TMP performed on patients with elevated
prostate speciﬁc antigen (PSA) and previous negative transrectal ultra-
sound guided prostate biopsy (TRUS).
Methods: Data has been collected retrospectively for 327 patients un-
dergoing TMP at Bart's and the London NHS Trust over a 6 year period
(2009 - 2014).
Results: Mean age of patients was 65 years (45 - 83) with 5.2% undergoing
their ﬁrst biopsy and at least 11.9% for restaging. Mean corrected PSA was
13.9 (0.05e132) and an average of 38 cores were taken per biopsy. Positive
histology was reported in 37% hence providing a signiﬁcant cancer detec-
tion ratewithmajority of the previous negative TRUS biopsies attributing to
larger prostates. The probability of detecting signiﬁcant prostate cancer in
larger prostates with multiple previous negative TRUS biopsies (4) is
rather low but we cannot comment on its clinical signiﬁcance.
Conclusion: From our datawe suggest that while TMP provides signiﬁcant
cancer detection rate it may be worth considering earlier TMP in cases of
previous negative TRUS biopsies.Posters: Vascular/Endovascular Surgery0062: ESTABLISHING THE ROLE OF SERIAL FDG-PET/CT IN ASSESSING
RESPONSE TO ANTIBIOTICS IN PATIENTS WITH INFECTED PROSTHETIC
VASCULAR GRAFTS
A. Mitra*, T. Wagner, J. Constantinou, M. Davis. Royal Free Hospital, UK
Aim: Evaluation of serial 18F-ﬂuorodeoxyglucose positron emission/
computed tomography (FDG-PET/CT) in monitoring response to treatment
in infected grafts.
Methods: Seven patients with infected aortic grafts on long-term antibi-
otics underwent serial FDG-PET/CT, from February 2013- July 2014. Scans
were evaluated for pattern, grade of uptake from one(not infected) to
ﬁve(deﬁnite infection) and maximal standardised uptake value (SUVmax).
The clinical course was retrospectively reviewed.
Results: All patients had two scans, four patients had three and one pa-
tient had ﬁve scans.
Qualitatively, the intensity of FDG uptake reduced with time. The median
uptake grade in the ﬁrst scans was 4 compared to 2 in the second. There
was no difference in the mean SUVmax between groups (9.6 ±4.7 versus
8.5 ±4.1) p¼0.37, nor a signiﬁcant reduction in SUVmax with time, p¼0.97.
Results after three scans demonstrated a reduction in grade of uptake (4.5,
3.5, 3 respectively) but no difference in SUVmax between groups, p¼0.99.
Conclusion: The reduction in grade of FDG uptake may represent a
reduction in the overall extent of infection. As all scans remained positive,
despite a clinical improvement, it may be that FDG-PET/CT is not a useful
modality in monitoring clinical response to antibiotic therapy in patients
with infected vascular grafts.
0107: AN AUDIT OF LOWER EXTREMITY AMPUTATION PRACTICE IN A
UK VASCULAR CENTRE
J. Mickleburgh 1,*, M. Gooseman 2, D. Drury 3. 1University of Shefﬁeld, UK;
2Northern General Hospital, UK; 3Doncaster Royal Inﬁrmary, UK
Aim: Lower extremity amputation is associated with signiﬁcant morbidity
and mortality. As such amputation is subject to clear guidelines asproduced by the UK Vascular Society. We aimed to measure how a UK
vascular centre performs against these standards.
Methods: We used theatre records to identify all patients undergoing
guillotine, below knee and above knee amputation over one year (Oct 13-
14). Each patient's indication for surgery, perioperative details, post-
operative progress and clinical investigations were subsequently
established.
Results: 33 patients were undergoing lower extremity amputation.
BKA:AKA ratio was 1.2 and unplanned revision surgery was 3%. In-hospital
mortality was 15%. Less than 65% of operations were undertaken by doc-
tors of consultant grade. There was a 41 day median length of stay. All
patients had a low albumin level preoperatively and 47% were anaemic.
Conclusion: In-hospital mortality was within expected range while revision
surgery had a lower rate than expected. We would advise consultant sur-
geon and anaesthetist presence in the operating theatre even if accompa-
nied by very senior trainees. We would also recommend close attention to
nutritional status in the pre-operative work up. Adopting these small
changes and ensuring compliance with national standards could further
improve outcomes for patients undergoing lower extremity amputation.
0119: AUDIT OF COMPLIANCE WITH THE VSGBI QUALITY
IMPROVEMENT FRAMEWORK FOR MAJOR LIMB AMPUTATIONS AT
THE ROYAL CORNWALL HOSPITAL
H. Modi*, J. Lynch, K. Woodburn. Royal Cornwall Hospital, UK
Aim: To assess compliance with the VSGBI Quality Improvement Frame-
work (QIF) for major amputation surgery at the Royal Cornwall Hospital.
Methods: The records of all patients undergoing major lower limb am-
putations between October 2012 and October 2013 were retrospectively
reviewed. Perioperative care was assessed in relation to the criteria out-
lined in the QIF.
Results: 26 patients underwent major lower limb amputations during the
audit period, of which 19 were male. The median age was 72 years (range:
48-91). 15 patients underwent a BKA and 11 underwent an AKA. Pre-
operatively, 77% were assessed by a consultant anaesthetist and 58% were
assessed by the rehabilitation team. 89% were prescribed VTE prophylaxis.
27% of cases were performed on an emergency list, of which 71% had their
procedure within 48 hours. All patients were anaesthetised by a FRCA-
qualiﬁed anaesthetist and all were operated on by a suitably trained sur-
geon. Post-operatively, all patients were reviewed by the rehabilitation
team. The 30-day mortality rate was 12%.
Conclusion: Whilst our institutionmet many of the target criteria outlined
in the QIF, there were a number of shortcomings. In order to address these
deﬁciencies, we propose an “Amputation Pathway” which encapsulates all
aspects of the quality improvement framework.
0189: OUTCOMES OF REGIONAL TRANSFERS OF RUPTURED ABDOMINAL
AORTIC ANEURYSMS
V. Proctor*, M. Lee, A. Nassef. Shefﬁeld Vascular Institute, UK
Aim: Vascular services are provided on a centralised basis. The VSQIP
programme has improved mortality after AAA repair but local experience
suggests those transferred with a ruptured AAA have increased morbidity.
Methods: We compared morbidity and 30-day mortality for operated
ruptured AAAs at our unit over a two-year period. Occurrence of transfer
and distance (as a proxy for time) to deﬁnitive care were recorded. Dis-
tance to deﬁnitive care was calculated from home postcode to local hos-
pital and then to vascular centre.
Results: Transfer did not statistically increase mortality (p¼0.59), but was
associated with increased morbidity (p¼0.06). ROC curve analysis sug-
gested that the highest rate of complications was seen in those who
travelled more than 8.9 miles. Distance to care of more than 13.9 miles was
associated with serious complications such as ischaemic colitis and those
affecting extremities.
Conclusion: Our results suggest no difference in mortality related to
transfer, but distance to deﬁnitive care is associated with increased risk
of complications. We did not consider management during transfer or
pre-operatively, both of which impact on outcome. We plan further
work to look at pre-transfer management and the development of post-
